Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06207370
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-12-21
Brief Title:
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Sponsor:
60 Degrees Pharmaceuticals LLC
Organization:
60 Degrees Pharmaceuticals LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-21
First Submit QC Date:
January 4 2024
Study First Post Date:
2024-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-18
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL